Causes, Risk Factors, and Prevention of Gastrointestinal Stromal Tumors

Learn about the risk factors for gastrointestinal stromal tumors (GIST). Because the cause of most GISTs is not completely understood, it is not known whether you can lower your risk.

What causes GISTs?

GISTs are rare tumors. Researchers have found a few risk factors that make a person more likely to develop GISTs, but most risk factors remain unknown.

Researchers have made great progress in understanding how certain gene changes (mutations) can cause normal cells to become cancerous. For example, some genes contain instructions for controlling when our cells grow and divide. Changes in these genes can lead to cancer growth.

Gene changes that can lead to GISTs

A small number of families have GISTs that are inherited or caused by a gene mutation passed down from parent to child. This is more common in younger people diagnosed with a GIST.

Most gene mutations related to GISTs are not inherited. These changes occur randomly and are called acquired or sporadic.

A few specific gene changes have been linked to developing GISTs. The most common gene changes in GIST tumors occur in the KIT and PDGFRA genes.

About 80% of GISTs have a change in the KIT gene. This gene directs cells to make the KIT protein (also known as CD117), which causes the cells to grow and divide.

Usually, the KIT gene is inactive in interstitial cells of Cajal (ICCs), which GISTs develop from. The KIT gene is only active if there is a need for more ICCs. But the gene change in most GISTs causes the KIT gene to always be turned on, so the cells are always growing and dividing.

When KIT gene changes are inherited, the condition is called Familial GIST syndrome.

In about 5% to 10% of GISTs, the cancer cells have a change in the PDGFRA gene. This gene change causes ICCs to grow and divide more than usual, increasing the chance of developing a GIST.

Inherited gene changes in PDGFRA are a less common cause of Familial GIST syndrome.

 

SDH gene changes can be seen in GIST tumors that do not have the more common KIT or PDGFRA gene changes. Normally, the SDH gene helps control how cells produce energy, grow, and divide. However, changes in this gene can lead to uncontrolled cell growth and cancer.

Gene changes in SDH can be inherited or acquired.

Carney-Stratakis syndrome is an inherited SDH gene change that can increase the risk of GISTs and paragangliomas. These tumors may occur at a young age.

Carney triad is an acquired change in SDH gene expression that can increase the risk of GIST tumors, paragangliomas, and pulmonary chondromas.

In rare cases, GISTs may not have these gene changes but have other changes in BRAF, FGFR1 or NTRK3 genes. Understanding the gene changes of GIST cells can be important for choosing the best treatment and understanding the outlook (prognosis).

Risk factors for GISTs

A risk factor is anything that affects your chance of getting a disease such as cancer. Different cancers have different risk factors.

But having a risk factor, or even several, does not mean that a person will get the disease. Many people who have a GIST may have few or no known risk factors.

 GISTs are rare, but they are most common in:

  • People over the age of 50
  • People who live in certain regions of China, Taiwan, Korea, and Norway
  • Black Americans and Asian or Pacific Islander Americans compared to White Americans

Researchers have found a few other risk factors that may increase the chance of having a GIST.

Genetic risk factors

Most GISTs have no clear cause. In rare cases, though, inherited gene changes have been found to cause GISTs in several members of the same family.

This is a rare, inherited condition that leads to an increased risk of developing GISTs. People with this syndrome tend to develop GISTs at a younger age than when they usually occur. They are also more likely to have more than one GIST.

This syndrome is most often caused by a change in the KIT or PDGFRA gene, which causes ICCs to constantly grow and divide.

Sometimes people with familial GIST syndrome also have skin spots like those seen in patients with neurofibromatosis (discussed below).

For more information, see Familial GIST Syndrome.

This condition is caused by a defect in the NF1 gene. This gene change might be inherited from a parent, but in some cases, the change occurs before birth, without being inherited.

People affected by this syndrome often have many benign (noncancerous) nerve tumors, called neurofibromas, starting when they are young. These tumors form under the skin and in other parts of the body. These people also typically have tan or brown spots on the skin (café au lait spots).

People with NF1 have a higher risk of GISTs, most often in the small intestine, as well as some other types of cancer.

For more information, see Neurofibromatosis Type 1.

People with this rare inherited condition have an increased risk of GISTs, most often in the stomach, as well as nerve tumors called paragangliomas. GISTs often develop when these people are in their teens or 20s. They are also more likely to have more than one GIST.

This syndrome is caused by a change in one of the SDH genes, which is passed from parent to child.

 

Environmental risk factors

No environmental or other risk factors for developing GISTs have been identified.

Can GISTs be prevented?

The only known risk factors for GISTs can’t be changed. There are no known lifestyle-related or environmental causes of GISTs, so we do not know of any way to protect against these cancers.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):298-302.

National Cancer Institute. Childhood Gastrointestinal Stromal Tumors Treatment. Accessed at https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-gist-treatment-pdq on December 17, 2025.

National Cancer Institute. Gastrointestinal Stromal Tumors Treatment. Accessed at https://www.cancer.gov/types/soft-tissue-sarcoma/hp/gist-treatment-pdq on December 4, 2025.

Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39-46.

Van Tine BA. Chapter 90: Sarcomas of Soft Tissue. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2019.

Last Revised: March 10, 2026

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.